{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:18:07Z","timestamp":1787163487687,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jdcr.2025.11.036","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T16:26:31Z","timestamp":1765988791000},"page":"119-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Perioral dermatitis secondary to topical clascoterone 1%"],"prefix":"10.1016","volume":"68","author":[{"given":"Megan","family":"Noda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munther","family":"Zureigat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdcr.2025.11.036_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298155","article-title":"The efficacy of topical clascoterone versus systematic spironolactone for treatment of acne vulgaris: a systematic review and network meta-analysis","volume":"19","author":"Basendwh","year":"2024","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jdcr.2025.11.036_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.36849\/JDD.7000","article-title":"Efficacy and Safety of 1% clascoterone cream in patients aged > 12 years with acne vulgaris","volume":"22","author":"Hebert","year":"2023","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jdcr.2025.11.036_bib3","series-title":"Dermatology","author":"Bolognia","year":"2012"},{"issue":"1","key":"10.1016\/j.jdcr.2025.11.036_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2023.2296855","article-title":"The primary role of sebum in the pathophysiology of acne vulgaris and its therapeutic relevance in acne management","volume":"35","author":"Del Rosso","year":"2024","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.jdcr.2025.11.036_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1528-1167.2010.02917.x","article-title":"Carbamazepine coadministration with an oral contraceptive: effects on steroid pharmacokinetics, ovulation, and bleeding","volume":"52","author":"Davis","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.jdcr.2025.11.036_bib6","article-title":"Isotretinoin and neuropsychiatric side effects: continued vigilance is needed","volume":"6","author":"Bremner","year":"2021","journal-title":"J Affect Disord Rep"},{"issue":"1","key":"10.1016\/j.jdcr.2025.11.036_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/DER.0000000000000307","article-title":"Propylene glycol in contact dermatitis: a systematic review","volume":"29","author":"McGowan","year":"2018","journal-title":"Dermatitis"},{"issue":"5","key":"10.1016\/j.jdcr.2025.11.036_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/1346-8138.16325","article-title":"Seven cases of contact dermatitis due to stearyl alcohol contained in topical medications","volume":"49","author":"Nishioka","year":"2022","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2025.11.036_bib9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaip.2015.01.025","article-title":"A case of systemic contact dermatitis secondary to edetate disodium","volume":"3","author":"Rajan","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.jdcr.2025.11.036_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/cod.14731","article-title":"Localised hypersensitivity reaction to polysorbate 80 during secukinumab treatment: a case of injection-site contact urticaria","volume":"92","author":"Berna-Rico","year":"2025","journal-title":"Contact Dermatitis"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625006666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625006666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:43:06Z","timestamp":1778931786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512625006666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":10,"alternative-id":["S2352512625006666"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.11.036","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioral dermatitis secondary to topical clascoterone 1%","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.11.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}